12:14 PM EDT, 06/26/2025 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Thursday it launched a private placement of 666,497 common shares at $7 per share and warrants to buy up to 666,497 shares with an exercise price of $7 per warrant.

The gross proceeds from the offering, expected to close on or before Monday, are estimated at about $4.7 million, according to a regulatory filing.

If all warrants are exercised following certain regulatory milestones related to elraglusib, the company could receive up to an additional $4.7 million in proceeds.

Actuate said it plans to use the net proceeds for working capital and general corporate purposes.

The company also said it signed a registration rights agreement with the investors to register the resale of the shares and underlying warrant shares.

The company's shares were down over 2% in recent trading.

Price: 6.29, Change: -0.15, Percent Change: -2.33